↓ Skip to main content

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

Overview of attention for article published in The Lancet HIV, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

news
1 news outlet
twitter
21 X users
facebook
3 Facebook pages

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
122 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
Published in
The Lancet HIV, April 2019
DOI 10.1016/s2352-3018(19)30053-0
Pubmed ID
Authors

Trevor A Crowell, Donn J Colby, Suteeraporn Pinyakorn, Carlo Sacdalan, Amélie Pagliuzza, Jintana Intasan, Khunthalee Benjapornpong, Kamonkan Tangnaree, Nitiya Chomchey, Eugène Kroon, Mark S de Souza, Sodsai Tovanabutra, Morgane Rolland, Michael A Eller, Dominic Paquin-Proulx, Diane L Bolton, Andrey Tokarev, Rasmi Thomas, Hiroshi Takata, Lydie Trautmann, Shelly J Krebs, Kayvon Modjarrad, Adrian B McDermott, Robert T Bailer, Nicole Doria-Rose, Bijal Patel, Robert J Gorelick, Brandie A Fullmer, Alexandra Schuetz, Pornsuk V Grandin, Robert J O'Connell, Julie E Ledgerwood, Barney S Graham, Randall Tressler, John R Mascola, Nicolas Chomont, Nelson L Michael, Merlin L Robb, Nittaya Phanuphak, Jintanat Ananworanich, RV397 Study Group, Julie A. Ake, Siriwat Akapirat, Meera Bose, Evan Cale, Phillip Chan, Sararut Chanthaburanun, Nampueng Churikanont, Peter Dawson, Netsiri Dumrongpisutikul, Saowanit Getchalarat, Surat Jongrakthaitae, Krisada Jongsakul, Sukalaya Lerdlum, Sopark Manasnayakorn, Corinne McCullough, Mark Milazzo, Bessara Nuntapinit, Kier On, Madelaine Ouellette, Praphan Phanuphak, Eric Sanders-Buell, Nongluck Sangnoi, Shida Shangguan, Sunee Sirivichayakul, Nipattra Tragonlugsana, Rapee Trichavaroj, Sasiwimol Ubolyam, Sandhya Vasan, Phandee Wattanaboonyongcharoen, Thipvadee Yamchuenpong

X Demographics

X Demographics

The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 122 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 16%
Student > Bachelor 13 11%
Student > Master 13 11%
Researcher 12 10%
Other 7 6%
Other 14 11%
Unknown 43 35%
Readers by discipline Count As %
Medicine and Dentistry 18 15%
Immunology and Microbiology 15 12%
Biochemistry, Genetics and Molecular Biology 10 8%
Agricultural and Biological Sciences 7 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Other 16 13%
Unknown 50 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2021.
All research outputs
#1,681,173
of 25,385,509 outputs
Outputs from The Lancet HIV
#381
of 1,329 outputs
Outputs of similar age
#37,381
of 364,697 outputs
Outputs of similar age from The Lancet HIV
#17
of 36 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,329 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.4. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,697 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.